Keywords: emea, approves, cymbalta, gad, european, commission, approved

EMEA approves Cymbalta for GAD

Article | 01 September 2008

Print This

The European Commission has approved the use of US drug major Eli Lilly and Germany's Boehringer Ingelheim's Cymbalta (duloxetine) for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in